http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104478675-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F1-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104478675-B |
| titleOfInvention | One class contains derivative and the purposes of alkoxyphenyl radical and fluoroform phenyl propylene glycol structure |
| abstract | The present invention relates to the pharmaceutical field relevant to diabetes.Specifically, the present invention relates to a class and transport son (SGLT2) inhibitor, its preparation method and the application in preparation treatment diabetes medicament containing the II type sodium dependent glucose of alkoxyphenyl radical and trifluoromethoxy benzaldehyde base propylene glycol structure.n wherein, Rn 1 be selected from Cn 1 -Cn 3 alkyl. |
| priorityDate | 2015-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.